Sukhwinder Singh Rai - Nov 15, 2022 Form 3/A - Amendment Insider Report for Skye Bioscience, Inc. (SKYE)

Role: Director
Signature: /s/ Kaitlyn Arsenault, as Attorney-in-Fact
Stock symbol: SKYE
Transactions as of: Nov 15, 2022
Transactions value $: $0
Form type: 3/A - Amendment
Date filed: 11/15/2022, 02:46 PM
Date Of Original Report: Nov 15, 2022
Previous filing: Nov 15, 2022
Next filing: Jan 9, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney